DR. AGARWAL'S EYE HOSP L Fair Value
DRAGARWQ · Healthcare · Current price ₹5,360
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹577 | 20% ROE fading to 14% over ~10 yrs, on ₹444 book |
| Relative P/E | ₹9,384 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹1,204 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹600 | Street consensus 12-month target price |
Is DR. AGARWAL'S EYE HOSP L undervalued?
DocStoX estimates the fair value of DR. AGARWAL'S EYE HOSP L at ₹2,694 per share, versus the current market price of ₹5,360. That puts the stock about -49.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹577), Relative P/E (₹9,384), Graham floor (₹1,204), Analyst target (₹600). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹577 (bear) to ₹2,694 (base) to ₹9,384 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on DR. AGARWAL'S EYE HOSP L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.